Cargando…

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations

BACKGROUND: Efforts have been made to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations using a variety of measures. Broncho-Vaxom (BV) is an immunomodulating agent that has shown potential benefit by balancing between immune stimulation and regulation in patients with CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Joon Young, Park, Yong Bum, An, Tai Joon, Yoo, Kwang Ha, Rhee, Chin Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559651/ https://www.ncbi.nlm.nih.gov/pubmed/37805515 http://dx.doi.org/10.1186/s12890-023-02665-4

Ejemplares similares

OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021)

Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
por: Roth, Michael, et al.
Publicado: (2017)

Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3β-Related T Regulatory Cell Insufficiency
por: Fu, Ran, et al.
Publicado: (2014)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD)
por: Choi, Joon Young, et al.
Publicado: (2020)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
por: Choi, Hye Sook, et al.
Publicado: (2019)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD
por: Choi, Joon Young, et al.
Publicado: (2023)

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial
por: Gao, Jinming, et al.
Publicado: (2014)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations
por: Yoon, Sunyoung, et al.
Publicado: (2019)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
por: Lee, Jung Su, et al.
Publicado: (2015)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

High urinary desmosine is associated with long-term mortality in patients with COPD
por: Kim, Changhwan, et al.
Publicado: (2023)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Broncho-Pneumonia
Publicado: (1906)

Broncho-Moniliasis
por: Sur, Taraknath
Publicado: (1921)

Broncho-Pneumonitis
por: Anderson, R. B.
Publicado: (1877)

Broncho-Pneumonio
por: Olive, N. A.
Publicado: (1896)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n1r1spnjfi41krcbt6ecrgo9l